GCR Interactive: Pharmaceuticals - Collision of Biologics - McDermott Will & Emery

GCR Interactive: Pharmaceuticals – Collision of Biologics


With the biologics market a growing focus of development across the globe, what role does antitrust have to play in order to ensure healthy price competition between reference-priced biologics and competing biosimilars?

Hendrik Viaene speaks in this session which will focus on this role, and what lessons can and cannot be learned from generics, to help ensure low cost versions are available to all.

David Giardina, Sidley Austin

Sheng Li, NERA Economic Consulting
Elaine Johnston, Allen & Overy
Hendrik Viaene, McDermott, Will & Emery

For more information, and to register, please click here.

Dig Deeper

Dallas, TX / McDermott Event / December 7, 2023

BIO BREAK: Dallas' Monthly Life Sciences Happy Hour

Boston, MA / McDermott Event / November 9, 2023

Life Sciences Dealmaking Symposium 2023

Paris, France / McDermott Event / November 7, 2023

European Health & Life Sciences Symposium 2023

Dallas, TX / McDermott Event / November 2, 2023

BIO BREAK: Dallas' Life Sciences Happy Hour

Webinar / IBA / November 1, 2023

IBA's Supply Chain and Sustainability Summit

Get In Touch